The stability in gross margins around 71% indicates consistent pricing power or cost control in production, which is positive. However, the low operating margin implies that operating expenses, likely R&D and sales overheads, are disproportionately high, limiting scalability. Investors should monitor whether revenue growth can leverage these fixed costs to improve operating profitability.

ROIC has been volatile, turning negative in early 2024 before recovering to positive but low levels, suggesting that the business model may be capital-intensive or inefficient. The low ROE of 2.2% corroborates this, as returns to equity holders remain minimal. This trend warrants investigation into asset utilization and margin expansion potential.

The extended CCC, up from 178 days in 2025Q1, indicates working capital inefficiency that ties up cash. While DSO has improved from 108 to 75 days, suggesting better receivables management, the high DIO is a concern. Comparing to peers, this could signal operational challenges in supply chain or sales cycles.

The discrepancy between trailing and forward multiples suggests that the market anticipates a turnaround in profitability, which aligns with the recent inflection to positive net income. However, the high EV/EBITDA indicates that the stock may be overvalued if growth assumptions are not met. A comparison to peers shows that Allot trades at a premium, which must be justified by superior growth or margins.